RT Journal Article
T1 [Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology].
T2 Recomendaciones sobre el tratamiento antitrombótico durante la pandemia COVID-19. Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Española de Cardiología.
A1 Vivas, David
A1 Roldán, Vanessa
A1 Esteve-Pastor, María Asunción
A1 Roldán, Inmaculada
A1 Tello-Montoliu, Antonio
A1 Ruiz-Nodar, Juan Miguel
A1 Cosín-Sales, Juan
A1 Gámez, José María
A1 Consuegra, Luciano
A1 Ferreiro, José Luis
A1 Marín, Francisco
A1 Revisores expertos, 
K1 Antithrombotics
K1 COVID-19
K1 Coronavirus
K1 SARS-CoV-2
K1 Thrombosis
AB The new coronavirus SARS-CoV-2, which gives rise to the highly contagious COVID-19 disease, has caused a pandemic that is overwhelming health care systems worldwide. Affected patients have been reported to have a heightened inflammatory state that increases their thrombotic risk. However, there is very scarce information on the management of thrombotic risk, coagulation disorders, and anticoagulant therapy. In addition, the situation has also greatly influenced usual care in patients not infected with COVID-19. This article by the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology aims to summarize the available information and to provide a practical approach to the management of antithrombotic therapy.
YR 2020
FD 2020-04-22
LK http://hdl.handle.net/10668/15423
UL http://hdl.handle.net/10668/15423
LA es
DS RISalud
RD Apr 6, 2025